milyon88 withdrawal
Mike Johnson Calls on Biden to 'Speak Up' as Trump Cabinet Picks TargetedBhopal Slum Rehabilitation Programme: Slum Dwellers To Be Provided Pucca Houses
InsurTech Market to Grow by USD 77.41 Billion (2024-2028), Driven by Business Efficiency Needs and AI Impacting Market Trends - TechnavioThe sentencing in ’s Manhattan criminal hush-money case has been postponed indefinitely while attorneys on both sides argue over its future given his recent election victory. Judge Juan Merchan, who is overseeing Trump’s case, did not provide a new sentencing date in his one-page scheduling order on Friday. Merchan said in his decision that Trump’s lawyers had to file their argument for dismissal by end of business on 2 December. Prosecutors have one week to respond. The development came in the wake of filings from prosecutors and defense lawyers over their views of how Trump’s case should proceed after he won the 2024 election against . Trump’s spokesperson, Steven Cheung, a statement calling the decision a “decisive win”. However, he repeated the president-elect’s claim that the case – which found Trump guilty on 34 felony counts of falsified business records – was a “hoax”. Trump’s lawyers on Tuesday asked Merchan to throw out the case, contending that dismissal was necessary “in order to facilitate the orderly transition of executive power”. Todd Blanche, Trump’s lead attorney and , and Emil Bove, the president-elect’s pick for principal associate deputy attorney general, complained that the Manhattan district attorney Alvin Bragg’s team “appears to not yet be ready to dismiss this politically motivated and fatally flawed case, which is what is mandated by the law and will happen as justice takes its course”. They argued that the US justice department was on the verge of dismissing Trump’s federal cases and pointed to a departmental memo that bars prosecution of sitting presidents. “As in those cases, dismissal is necessary here,” their filing said. “Just as a sitting president is completely immune from any criminal process, so too is President Trump as president-elect.” They claimed that if this case proceeds, it would “be uniquely destabilizing” and could “hamstring the operation of the whole governmental apparatus, both in foreign and domestic affairs”. They asked Merchan to give them until 20 December to file their push for dismissal. Prosecutors previously told Merchan that they planned on fighting Trump’s expected plans for dismissal in the aftermath of his recent presidential win. Prosecutors also said that other case proceedings should be put on pause until Trump’s dismissal argument is decided. Prosecutors disagreed that Trump’s case should be dismissed simply because appeals would not be decided before his inauguration. While they respected the presidency and understood the logistical issues, “no current law establishes that a president’s temporary immunity from prosecution requires dismissal of a criminal proceeding that was initiated at a time when the defendant was not immune from criminal prosecution, and that is based on unofficial conduct from which the defendant is also not immune.” The prosecution said that courts must respect the varying constitutional interests – the executive branch’s need for independence, and the judicial branch’s need for integrity. Prosecutors told Merchan that there were routes he could take other than outright dismissal, including “deferral of all remaining criminal proceedings until after the end of defendant’s upcoming presidential term”. Trump was found guilty of falsifying business records in an effort to sway the 2016 election on 30 May. The prosecution said that Trump falsely listed reimbursements to his then-lawyer, , who gave the adult film star Stormy Daniels $130,000 for her silence about a purported affair with Trump, as “legal expenses”. The jury reached their guilty verdict in less than 24 hours. These proceedings were the first time a US president – former or sitting – stood a criminal trial, as well as a conviction.
During her long-lasting career, Congresswoman Shirley Chisholm once stated, “Everyone, with the exception of the Black woman herself, has been interpreting the Black woman.” Now, Dr. Zinga Fraser , assistant professor at Brooklyn College , City University of New York and the director of the Shirley Chisholm Project of Brooklyn Women’s Activism, has amplified the story of trailblazer Chisholm in her new book, Shirley Chisholm In Her Own Words , which was released on Oct. 8 from University of California Press. Chisholm was the first Black woman elected to the United States Congress, representing New York’s 12th congressional district that includes Bedford Stuyvesant. She is also known for being the first Black woman to seek a major party's nomination for President of the United States, and the first woman to run for the Democratic Party’s nomination. The book is a collection of Chisholm’s most popular speeches and writings over the span of her 20-year career in the House of Representatives and beyond. It lays out Chisholm’s work as a Black feminist on topics like police brutality, abortion and civil rights for marginalized groups. As we approach her centennial birthday on Nov. 30, 2024, studying Chisholm's work can be a roadmap for understanding our current state of democracy, Dr. Fraser said. It also begs the question of whether society has truly progressed since her time. On the issue of reproductive rights, for example, Dr. Fraser said that Chisholm understood that the discussion went beyond the right to have access to an abortion. Instead, it was more so about reproductive justice and women’s right to choose, she said. Now, the overturning of Roe v. Wade in 2022 by the U.S. Supreme Court has left young girls and women with fewer rights than during the era of Chisholm. “All of the chapters throughout the book really showed Chisholm being a visionary in the ways in which she viewed the world,” said Dr. Fraser. “Students think, ‘Oh, that was, you know, 30 years ago or 50 years ago, and it's not as relevant.’ No, it's actually more relevant than when she was talking about.” Chisholm announced her run for the Democratic Party’s nomination in 1972 in Brooklyn against the presumed Republican nominee Richard Nixon. Though the book was written before President Joe Biden conceded and Vice President Kamala Harris became the Democratic nominee, readers can see many parallels in how Chisholm and Harris' campaigns were run. In addition to both nominees identifying as Black women, Harris and Chisholm ran during high civil, economic and political stress, Dr. Fraser noted. Beyond highlighting Chisholm’s historic firsts, Dr. Fraser said she wants people to understand that she was an extremely savvy strategist and her stance during the political climate at that time is something to be revered. “The most important thing I want people to take away is the important role Chisholm played intellectually and politically in our country,” said Fraser. “Chisholm wasn't just a first or a symbol, she was a strategist. She was an intellectual. She was very thoughtful in the ways that she approached legislation, and that in many ways, she was a visionary."
Reed scores 15 off the bench, Tulsa downs Mississippi Valley State 93-48
First treatment in 50 years for serious asthma attacks is ‘game-changer’
NEW YORK , Nov. 27, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The global biomaterials market size is estimated to grow by USD 12.76 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 5.68% during the forecast period. Increasing prevalence of musculoskeletal diseases and disorders is driving market growth, with a trend towards increasing number of joint replacement and arthroplasty surgeries. However, high cost of bioimplants and surgeries poses a challenge.Key market players include Algenesis Corp., Artoss Inc., BASF SE, Berkeley Advanced Biomaterials, CAM Bioceramics BV, Carpenter Technology Corporation, Celanese Corp., CeramTec GmbH, CoorsTek Inc., Corbion nv, Covestro AG, Dimension Inx., Evonik Industries AG, Gelita AG, Koninklijke DSM NV, Mitsubishi Chemical Group Corp., Noble Biomaterials Inc., Riton Biomaterial Co. Ltd., Victrex Plc, and Zeus Co. Inc.. AI-Powered Market Evolution Insights. Our comprehensive market report ready with the latest trends, growth opportunities, and strategic analysis- View Free Sample Report PDF Key Market Trends Fueling Growth The biomaterials market is experiencing significant growth due to trends in regenerative medicine and personalized medicine. Key therapeutic areas include wound healing, plastic surgery, and implantable devices. Biocompatibility is crucial for these applications, with a focus on bioabsorbable biomaterials for orthopedic applications and metallic, polymeric, and ceramic biomaterials for various medical devices. Durability and long-term performance are essential factors, with tricalcium phosphate, polylactic acid, and polyglycolic acid being popular choices. Cardiovascular and dental applications are also driving demand, with research in bioresorbable materials and nanoparticles/microspheres for drug delivery systems. Manufacturing technologies, such as biofabrication and 3D printable biomaterials, are innovating the field. An aging population, musculoskeletal disorders, and chronic diseases like osteoarthritis and cardiovascular diseases require advanced medical solutions. Environmental risks and waste management are concerns, with eco-friendly alternatives and recycling efforts underway. Research grants, tax incentives, and minimally invasive procedures/surgical techniques support market growth. Preclinical and clinical trials are ongoing for traditional treatment modalities and new technologies like nanotechnology, autologous treatments, and allograft-based treatments. Bioengineering and biologically derived materials are also gaining attention, with a focus on controlled degradation, mechanical strength, and controlled release kinetics for sustained therapeutic levels. Infection rates and healing processes are key considerations, with a focus on minimizing risks and enhancing outcomes. The global biomaterials market is experiencing growth due to the increasing number of outpatient joint replacement procedures. These surgeries, including knee, hip, shoulder replacements, and trauma and extremities reconstruction, are becoming more common due to advancements in surgical techniques, implants, and post-operative care management. Outpatient procedures offer several advantages, such as shorter hospital stays, increased patient satisfaction, and reduced costs for both patients and healthcare systems. These benefits have led to a preference for outpatient joint replacement surgeries over traditional inpatient procedures. Insights on how AI is driving innovation, efficiency, and market growth- Request Sample! Market Challenges The biomaterials market is experiencing significant growth due to the increasing demand for regenerative medicine and personalized medicine. Biomaterials find applications in various therapeutic areas such as wound healing, plastic surgery, implantable devices, and orthopedic applications. Challenges include ensuring biocompatibility, durability, and long-term performance for bioabsorbable biomaterials like tricalcium phosphate and polylactic acid. Biocompatibility is crucial for cardiovascular and dental applications. Manufacturing technologies like nanotechnology and biofabrication are driving innovation in biomaterials. However, challenges remain in waste management and environmental risks. Recycling and minimally invasive procedures are key areas of focus. Key therapeutic areas include musculoskeletal disorders, neurological applications, and ophthalmology applications. Drug delivery systems using nanoparticles, microspheres, and hydrogels are gaining popularity. Biodegradable materials like polyglycolic acid and ceramics offer controlled degradation and sustained therapeutic levels. The aging population and chronic diseases like osteoarthritis, cardiovascular diseases, and dental problems are driving demand for advanced medical technologies. Research grants, tax incentives, and innovative solutions are fueling investments in this field. However, challenges remain in ensuring corrosion resistance, infection rates, and healing processes. Traditional treatment modalities continue to face competition from biomaterials. Joint replacements and tissue engineering are major applications, with a focus on minimally invasive surgical techniques and preclinical and clinical trials. Biomaterials are also being explored for eco-friendly alternatives and autologous and allograft-based treatments. 3D printable biomaterials and bioengineering are promising areas of research. The future of biomaterials lies in their ability to provide controlled release kinetics, mechanical strength, and bioabsorbability. The biomaterials market faces a significant challenge due to the high cost of bioimplants and related surgeries, limiting their adoption in both developed and developing countries. Bioimplants, made from a combination of biological, mechanical, and optical elements, offer desirable properties for functioning within the human body. Biocompatibility, bio-adhesion, bio-functionality, and corrosion resistance are essential properties that determine the suitability of materials for bioimplants. However, expensive materials like ceramics, polymers, bone allografts, metal alloys, and non-metals hinder accessibility for low-income populations. Insights into how AI is reshaping industries and driving growth- Download a Sample Report Segment Overview This biomaterials market report extensively covers market segmentation by 1.1 Metallic 1.2 Ceramic 1.3 Polymers 1.4 Natural 2.1 Orthopedic 2.2 Cardiovascular 2.3 Dental 2.4 Neurology 2.5 Others 3.1 North America 3.2 Europe 3.3 Asia 3.4 Rest of World (ROW) 1.1 Metallic- Metallic biomaterials, including 316L stainless steel, cobalt-chromium alloys, and titanium-based alloys, are essential engineering materials used in biomedical applications due to their superior thermal conductivity and mechanical properties. These materials are extensively utilized in the manufacturing of medical devices for cardiovascular, dental, and orthopedic applications. Metallic biomaterials offer superior mechanical properties such as high fracture toughness, ductility, and yield strength, making them suitable for load-bearing or permanent deformation. In orthopedic procedures like joint replacements, orthopedic fixations, and stents, metallic biomaterials are widely used due to their strength and resistance to fatigue degradation. Additionally, the increasing demand for neuromuscular stimulation devices, which require good electrical conductivity, will drive the growth of the metallic segment of the biomaterials market during the forecast period. Download complimentary Sample Report to gain insights into AI's impact on market dynamics, emerging trends, and future opportunities- including forecast (2024-2028) and historic data (2018 - 2022) Research Analysis The Biomaterials Market encompasses a wide range of materials used in various therapeutic areas, including regenerative medicine and personalized medicine. These materials find applications in wound healing, plastic surgery, implantable devices, and orthopedic applications, among others. Biocompatibility is a crucial factor in the success of these materials, with bioabsorbable biomaterials gaining popularity due to their ability to degrade over time and be replaced by natural tissue. Nanoparticles and microspheres are also key components, enabling controlled release kinetics for sustained therapeutic levels of therapeutic agents. Ceramics, hydrogels, and polymeric constructs are also commonly used, with nanotechnology and 3D printable biomaterials offering innovative solutions. Biologically derived materials and eco-friendly alternatives are also gaining traction in the market. Healthcare investments continue to fuel the development of new and advanced biomaterials, driving the growth of this industry. Market Research Overview The Biomaterials Market encompasses a wide range of materials used in medical applications, including regenerative medicine and personalized medicine. Therapeutic areas such as wound healing, plastic surgery, and implantable devices are major sectors. Biocompatibility is a key consideration for biomaterials, with bioabsorbable biomaterials gaining popularity in orthopedic applications. Metallic, polymeric, ceramic, and natural biomaterials are commonly used. Durability and long-term performance are essential for medical devices, but waste management and environmental risks are growing concerns. Manufacturing technologies like biofabrication and 3D printing are driving innovation. Key therapeutic areas include cardiovascular applications, dental applications, neurological applications, and ophthalmology applications. Drug delivery systems, nanoparticles, microspheres, and hydrogels are used for controlled release of therapeutic agents. Biodegradability, chronic disease management, and advanced medical technologies are current trends. The aging population and increasing prevalence of musculoskeletal disorders, cardiovascular diseases, and dental problems drive market growth. Research grants, tax incentives, and healthcare investments support innovation. Minimally invasive procedures and surgical techniques, preclinical and clinical trials, and eco-friendly alternatives are also significant factors. Table of Contents: 1 Executive Summary 2 Market Landscape 3 Market Sizing 4 Historic Market Size 5 Five Forces Analysis 6 Market Segmentation Type Metallic Ceramic Polymers Natural Application Orthopedic Cardiovascular Dental Neurology Others Geography North America Europe Asia Rest Of World (ROW) 7 Customer Landscape 8 Geographic Landscape 9 Drivers, Challenges, and Trends 10 Company Landscape 11 Company Analysis 12 Appendix About Technavio Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contacts Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 Email: [email protected] Website: www.technavio.com/ SOURCE TechnavioShane Bieber says bonds led to re-signing with Guardians after he missed '24 following elbow surgeryWhy your favorite catalogs are smaller this holiday season
'I'm Insulted': Kennedy Grills U.S. General On Anti-Trump Remarks I Heated Mass Deportations Hearing
Scientists have found a new treatment for people with asthma and chronic obstructive pulmonary disease (COPD) that may be more effective than current options. Over the past 50 years, treatment options in the event of an asthma or COPD attack—a similar event—have been relatively unchanged. "The only treatment we have for attacks are steroids, which aren't always effective and can have serious side effects," Professor Mona Bafadhel, lead investigator of a trial of a new treatment from King's College London, told Newsweek . When patients are given steroids, such as a medication called prednisolone, to treat an asthma attack, it may reduce lung inflammation but increase the risk of serious conditions such as diabetes or osteoporosis. Many patients on steroids fail treatment, which means they may need more steroids, have to be re-hospitalized or die within 90 days. Bafadhel's team studied the effect of injecting patients with benralizumab, a lab-made protein designed to act like an antibody, targeting specific white blood cells called eosinophils to reduce lung inflammation. Eosinophils are responsible for approximately 30 percent of COPD flare-ups and half of asthma attacks. Benralizumab is currently used to treat severe asthma but is not used to treat COPD or asthma attacks. Bafadhel's team randomly assigned more than 150 asthma and COPD patients being treated in emergency departments of English hospitals into three groups: one received benralizumab and dummy tablets, one received steroids and a dummy injection, and one received both benralizumab and steroids. The ABRA study was a double-blind, double-dummy, placebo-controlled trial, so neither the patients nor the researchers knew who got what. After 28 days, respiratory symptoms —coughing, wheezing, breathlessness and sputum—were better with benralizumab. After 90 days, there were four times fewer people in the benralizumab group who failed treatment, compared to the group receiving steroid drugs. People who were given benralizumab also reported an improved quality of life. Asthma is a chronic lung condition that inflames and narrows the airways in the lungs. It affects 6.2 percent of children and 8.7 percent of adults in the U.S., according to data from the Centers for Disease Control and Prevention ( CDC ) collected in 2022. It can make breathing difficult and trigger symptoms such as wheezing, coughing and shortness of breath. "It's a common condition, but for many, it's a major condition that interferes with daily activities such as work, exercise and caregiving," said Bafadhel. "An asthma attack can be serious and life-threatening when you experience rapid worsening or shortness of breath, and you see no improvement in your symptoms after using an inhaler." COPD is a long-term lung condition in which the airways become damaged or blocked, often because of smoking or air pollution. Nearly 16 million U.S. adults have COPD, according to the CDC. Geoffrey Pointing, 77, who took part in the study, said in a statement: "Honestly, when you're having a flare up, it's very difficult to tell anybody how you feel—you can hardly breathe. "Anything that takes that away and gives you back a normal life is what you want. But on the injections, it's fantastic. I didn't get any side effects like I used to with the steroid tablets." Pointing said that steroid treatments used to interfere with his sleep, but he could sleep well on benralizumab. "I'm just grateful I took part and that everyone involved in the ABRA study are trying to give me a better life," he said. Bafadhel said in a statement that this treatment "could be a game-changer for people with asthma and COPD" and that benralizumab was "safe and effective." Is there a health problem that's worrying you? Do you have a question about asthma? Let us know via health@newsweek.com. We can ask experts for advice and your story could be featured in Newsweek. Reference Ramakrishnan, S., Russell, R. E. K., Mahmood, H. R., Krassowska, K., Melhorn, J., Mwasuku, C., Pavord, I. D., Bermejo-Sanchez, L., Howell, I., Mahdi, M., Peterson, S., Bengtsson, T., Bafadhel, M. (2024). Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial, The Lancet Respiratory Medicine . https://doi.org/10.1016/S2213-2600(24)00299-6President-elect Donald Trump arrives to speak at a meeting of the House GOP conference, followed by Rep. Elise Stefanik, R-N.Y., last week in Washington. Alex Brandon/Associated Press NEW YORK — A number of President-elect Donald Trump ‘s most prominent Cabinet picks and appointees have been targeted by bomb threats and “swatting attacks,” Trump’s transition team said Wednesday. The FBI said it was investigating. “Last night and this morning, several of President Trump’s Cabinet nominees and Administration appointees were targeted in violent, unAmerican threats to their lives and those who live with them,” Trump transition spokesperson Karoline Leavitt said in a statement. She said the attacks ranged from bomb threats to swatting, in which attackers initiate an emergency law enforcement response against a target victim under false pretenses. The tactic has become a popular one in recent years. Leavitt said law enforcement and other authorities acted quickly to ensure the safety of those who were targeted and Trump and his transition team are grateful. Among those targeted were New York Rep. Elise Stefanik, Trump’s pick to serve as the next ambassador to the United Nations; Matt Gaetz, Trump’s initial pick to serve as attorney general; and former New York congressman Lee Zeldin, who has been tapped to lead the Environmental Protection Agency. Law enforcement officials are also looking into whether Susie Wiles, Trump’s incoming chief of staff, and Pam Bondi, the former Florida attorney general whom Trump has chosen as Gaetz’s replacement, and other incoming administration officials were also victims – as well as how each was targeted, according to a law enforcement official who spoke on condition of anonymity as the investigation continues. Wiles and Bondi did not immediately respond to requests for comment. The FBI said in a statement that it was “aware of numerous bomb threats and swatting incidents targeting incoming administration nominees and appointees” and was investigating with its law enforcement partners. The FBI added: “We take all potential threats seriously, and as always, encourage members of the public to immediately report anything they consider suspicious to law enforcement.” A pipe bomb threat targeting me and my family at our home today was sent in with a pro-Palestinian themed message. My family and I were not home at the time and are safe. We are working with law enforcement to learn more as this situation develops. We are thankful for the swift... — Lee Zeldin (@LeeMZeldin) November 27, 2024 White House spokesperson Saloni Sharma said President Biden had been briefed and the White House is in touch with federal law enforcement and Trump’s transition team. Biden “continues to monitor the situation closely,” Sharma said, adding the president and his administration “condemn threats of political violence.” Stefanik’s office said that, on Wednesday morning, she, her husband, and their 3-year-old son were driving home from Washington for Thanksgiving when they were informed of a bomb threat to their residence in Saratoga County. Her office said “New York State, County law enforcement, and U.S. Capitol Police responded immediately with the highest levels of professionalism.” The New York State Police said a team was dispatched to sweep Stefanik’s home on Wednesday morning in response to the bomb threat but did not locate any explosive devices. The agency directed further questions to the FBI. Zeldin said in a social media post that he and his family had been threatened. “A pipe bomb threat targeting me and my family at our home today was sent in with a pro-Palestinian themed message,” he wrote on X . “My family and I were not home at the time and are safe. We are working with law enforcement to learn more as this situation develops.” Police in Suffolk County, Long Island, said emergency officers responded to a bomb threat Wednesday morning at an address listed in public records as Zeldin’s home and were checking the property. In Florida, the Okaloosa County sheriff’s office said on Facebook that it “received notification of a bomb threat referencing former Congressman Matt Gaetz’s supposed mailbox at a home in the Niceville area” around 9 a.m. Wednesday. While a family member resides at the address, the office said, Gaetz “is NOT a resident.” No threatening devices were found. Gaetz was Trump’s initial pick to serve as attorney general, but he withdrew from consideration after allegations that he paid women for sex and slept with underage women. Gaetz has vehemently denied any wrongdoing and said last year that a Justice Department investigation into sex trafficking allegations involving underage girls had ended with no federal charges against him. The threats follow a political campaign marked by disturbing and unprecedented violence. In July, a gunman opened fire at a Trump rally in Butler, Pennsylvania, grazing the then-candidate in the ear with a bullet and killing one of his supporters. The Secret Service later thwarted a subsequent assassination attempt at Trump’s West Palm Beach, Florida, golf course when an agent spotted the barrel of a gun poking through a perimeter fence while Trump was golfing. Trump was also the subject of an Iranian murder-for-hire plot, with a man saying he had been tasked with planning the assassination of the Republican president-elect. Also this week, authorities arrested a man they say posted videos on social media threatening to kill Trump, according to court documents. In one video posted on Nov. 13, Manuel Tamayo-Torres threatened to shoot the former president while holding what appeared to be an AR-15 style rifle, authorities said Among the other videos he posted was one from an arena in Glendale, Arizona on Aug. 23, the same day Trump held a campaign rally there, according to court papers. An attorney for Tamayo-Torres did not immediately respond to a request for comment Wednesday. Public figures across the political spectrum have been targeted in recent years by hoax bomb threats and false reports of shootings at their homes. About a year ago the FBI responded to an uptick in such incidents at the homes of public officials, state capitols and courthouses across the country around the holidays. Many were locked down and evacuated in early January after receiving bomb threats. No explosives were found and no one was hurt. Some of those targeted last year were Georgia Lt. Gov. Burt Jones, Boston Mayor Michelle Wu and Ohio Attorney General Dave Yost. This year, there was not just one but TWO assassination attempts on President Trump. Now some of his Cabinet nominees and their families are facing bomb threats. This is dangerous and unhinged. It is not who we are in America. Joe Biden and all Democrat leaders have an... https://t.co/0xZztX4DQo — Speaker Mike Johnson (@SpeakerJohnson) November 27, 2024 In Wu’s case, a male caller told police he had shot his own wife and tied another man up. When police and EMT responders arrived at the address given by the caller, they quickly realized it was the Boston mayor’s home. Wu, a Democrat, has also been targeted by many swatting calls since she took office in 2021. The judges overseeing the civil fraud case against Trump in New York and the criminal election interference case against him in Washington were both targeted earlier this year. Justice Department special counsel Jack Smith, who recently abandoned the two criminal cases he brought against Trump, was also the subject of a fake emergency call on Christmas Day last year. Earlier this year, schools, government buildings and the homes of city officials in Springfield, Ohio, received a string of hoax bomb threats after Trump falsely accused members of Springfield’s Haitian community of abducting and eating cats and dogs. And in 2022, a slew of historically Black colleges and universities nationwide were targeted with dozens of bomb threats, with the vast majority arriving during the celebration of Black History Month. The U.S. Capitol Police said in a statement Wednesday that anytime a member of Congress is the victim of a swatting’ incident, “we work closely with our local and federal law enforcement partners.” The force declined to provide further details, in part to “minimize the risk of copy-cats.” Republican House Speaker Mike Johnson called the threats “dangerous and unhinged.” “This year, there was not just one but TWO assassination attempts on President Trump,” he wrote on X . “Now some of his Cabinet nominees and their families are facing bomb threats.” He added: “It is not who we are in America.” Associated Press writers Colleen Long and Eric Tucker in Washington, Scott Bauer in Madison, Wisconsin, and Anthony Izaguirre in Albany, New York, contributed to this report. Comments are not available on this story. Send questions/comments to the editors. « Previous Next »